|
1
|
Wang W, Zhou H and Liu L: Side effects of
methotrexate therapy for rheumatoid arthritis: A systematic review.
Eur J Med Chem. 158:502–516. 2018.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Harigai M: Lymphoproliferative disorders
in patients with rheumatoid arthritis in the era of widespread use
of methotrexate: A review of the literature and current
perspective. Mod Rheumatol. 28:1–8. 2018.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Kleinschmidt-DeMasters BK, Damek DM,
Lillehei KO, Dogan A and Giannini C: Epstein Barr virus-associated
primary CNS lymphomas in elderly patients on immunosuppressive
medications. J Neuropathol Exp Neurol. 67:1103–1111.
2008.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Fukushima M, Katayama Y, Yokose N, Kura Y,
Sawada U, Kotani A and Yoshino A: Primary central nervous system
malignant lymphoma in a patient with rheumatoid arthritis receiving
low-dose methotrexate treatment. Br J Neurosurg. 27:824–826.
2013.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Hoshida Y, Xu JX, Fujita S, Nakamichi I,
Ikeda J, Tomita Y, Nakatsuka S, Tamaru J, Iizuka A, Takeuchi T and
Aozasa K: Lymphoproliferative disorders in rheumatoid arthritis:
Clinicopathological analysis of 76 cases in relation to
methotrexate medication. J Rheumatol. 34:322–331. 2007.PubMed/NCBI
|
|
6
|
Migita K, Miyashita T, Mijin T, Sakito S,
Kurohama H, Ito M, Toda K, Tsustumi K, Baba H, Izumi Y, et al:
Epstein-Barr virus and methotrexate-related CNS lymphoma in a
patient with rheumatoid arthritis. Mod Rheumatol. 23:832–836.
2013.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Liu W, Xue J, Yu S, Chen Q, Li X and Yu R:
Primary central nervous system lymphoma mimicking recurrent
depressive disorder: A case report. Oncol Lett. 9:1819–1821.
2015.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Shimada H, Dobashi H, Morimoto H, Kameda
T, Susaki K, Izumikawa M, Takeuchi Y, Nakashima S, Imataki O and
Bandoh S: Primary central nervous system lymphoma in a rheumatoid
arthritis patient treated with methotrexate: A case report. BMC Res
Notes. 8(88)2015.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Kikuchi J, Kaneko Y, Kasahara H, Emoto K,
Kubo A, Okamoto S and Takeuchi T: Methotrexate-associated
intravascular large B-cell lymphoma in a patient with rheumatoid
arthritis. Intern Med. 55:1661–1665. 2016.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Matsuda I and Hirota S:
Methotrexate-associated lymphoproliferative disorder masquerading
as multiple cerebral metastases. Br J Haematol.
180(628)2018.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Miyaza S, Matsuda R, Nakamura M, Nakagawa
I, Motoyama Y and Nakase H: Intracranial methotrexate-associated
lymphoproliferative disorder in rheumatoid arthritis. World
Neurosurg. 130:138–141. 2019.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Kawazoe M, Kaneko K and Nanki T:
Methotrexate-associated lymphoproliferative disorders in the
central nervous system and stomach: A case report. Medicine
(Baltimore). 99(e19850)2020.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Uneda A, Hirashita K, Kanda T, Yunoki M,
Yoshino K, Kurozumi K and Date I: rimary central nervous system
methotrexate-associated lymphoproliferative disorder in a patient
with rheumatoid arthritis: Case report and review of literature.
NMC Case Rep J. 7:121–127. 2020.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Kawano H, Kitamura T, Higuchi K and Nozaki
K: Primary central nervous system T-cell lymphoma as
methotrexate-associated lymphoproliferative disorders: Case report.
NMC Case Rep J. 8:253–259. 2021.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Ueno H, Ohno N, Abe T, Kimoto K, Matsuoka
C, Giga M, Naito H, Kono T, Takasu M, Kidani N, et al: Prognosis
prediction using magnetic resonance spectroscopy and oligoclonal
bands in central nervous system methotrexate-associated
lymphoproliferative disorder. Intern Med. 61:3733–3738.
2022.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Mizushima M, Ishi Y, Ikeda H, Echizenya I,
Otsuka T, Mitsuhashi T, Yamaguchi S and Fujimura M: Successful
treatment of intracranial methotrexate-associated
lymphoproliferative disorder without Epstein-Barr virus infection
using rituximab, methotrexate, procarbazine, and vincristine: A
case report. NMC Case Rep J. 9:237–242. 2022.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Ellman MH, Hurwitz H, Thomas C and Kozloff
M: Lymphoma developing in a patient with rheumatoid arthritis
taking low dose weekly methotrexate. J Rheumatol. 18:1741–1743.
1991.PubMed/NCBI
|
|
18
|
Gaulard P, Swerdlow SH, Harris NL,
Sundstrom C and Jaffe ES: Other iatrogenic
immunodeficiency-associated lymphoproliferative disorders. In:
Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H and
Thiele J (eds). WHO classification of tumours of haematopoietic and
lymphoid tissues. Revised 4th edition. IARC, Lyon, France,
pp462-464, 2017.
|
|
19
|
Rizzi R, Curci P, Delia M, Rinaldi E,
Chiefa A, Specchia G and Liso V: Spontaneous remission of
‘methotrexate-associated lymphoproliferative disorders’ after
discontinuation of immunosuppressive treatment for autoimmune
disease. Review of the literature. Med Oncol. 26:1–9.
2009.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Katsuyama T, Sada KE, Yan M, Zeggar S,
Hiramatsu S, Miyawaki Y, Ohashi K, Morishita M, Watanabe H,
Katsuyama E, et al: Prognostic factors of methotrexate-associated
lymphoproliferative disorders associated with rheumatoid arthritis
and plausible application of biological agents. Mod Rheumatol.
27:773–777. 2017.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Furukawa S, Oobu K, Moriyama M, Kawano S,
Sako S, Hayashida JN, Matsubara R, Ogata KI, Kiyoshima T and
Nakamura S: Oral methotrexate-related lymphoproliferative disease
presenting with severe osteonecrosis of the jaw: A case report and
literature review. Intern Med. 57:575–581. 2018.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Ruggiero SL, Dodson TB, Assael LA,
Landesberg R, Marx RE and Mehrotra B: American Association of Oral
and Maxillofacial Surgeons. American association of oral and
maxillofacial surgeons position paper on bisphosphonate-related
osteonecrosis of the Jaws-2009 update. J Oral Maxillofac Surg. 67
(Suppl):S2–S12. 2009.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Ficarra G and Beninati F:
Bisphosphonate-related osteonecrosis of the Jaws: An update on
clinical, pathological and management aspects. Head Neck Pathol.
1:132–140. 2007.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Ruggiero SL, Dodson TB, Aghaloo T, Carlson
ER, Ward BB and Kademani D: American association of oral and
maxillofacial surgeons' position paper on medication-related
osteonecrosis of the Jaws-2022 update. J Oral Maxillofac Surg.
80:920–943. 2022.PubMed/NCBI View Article : Google Scholar
|
